A detailed history of Motco transactions in Abb Vie Inc. stock. As of the latest transaction made, Motco holds 22,395 shares of ABBV stock, worth $4.03 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
22,395
Previous 2,227 905.61%
Holding current value
$4.03 Million
Previous $381,000 1060.63%
% of portfolio
0.45%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $3.3 Million - $4.02 Million
20,168 Added 905.61%
22,395 $4.42 Million
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $32,660 - $38,140
211 Added 10.47%
2,227 $381,000
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $9,269 - $10,561
58 Added 2.96%
2,016 $367,000
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $36,464 - $41,067
265 Added 15.65%
1,958 $303,000
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $2,538 - $2,938
19 Added 1.14%
1,693 $252,000
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $10,733 - $13,356
81 Added 5.08%
1,674 $225,000
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $27,042 - $31,142
187 Added 13.3%
1,593 $253,000
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $179,249 - $214,967
-1,296 Reduced 47.96%
1,406 $227,000
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $205,475 - $235,666
1,531 Added 130.74%
2,702 $363,000
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $6,192 - $7,873
-45 Reduced 3.7%
1,171 $179,000
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $59,522 - $73,851
451 Added 58.95%
1,216 $197,000
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $6,982 - $8,835
-65 Reduced 7.83%
765 $104,000
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $11,573 - $12,893
110 Added 15.28%
830 $93,000
Q1 2021

Apr 16, 2021

SELL
$102.3 - $112.62 $20,255 - $22,298
-198 Reduced 21.57%
720 $78,000
Q4 2020

Feb 05, 2021

SELL
$80.49 - $108.67 $24,147 - $32,601
-300 Reduced 24.63%
918 $98,000
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $28,178 - $33,072
328 Added 36.85%
1,218 $106,000
Q2 2020

Jul 15, 2020

BUY
$73.37 - $98.18 $2,274 - $3,043
31 Added 3.61%
890 $87,000
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $10,771 - $16,330
167 Added 24.13%
859 $66,000
Q4 2019

Feb 06, 2020

SELL
$72.13 - $90.25 $27,553 - $34,475
-382 Reduced 35.57%
692 $62,000
Q3 2019

Nov 05, 2019

SELL
$62.98 - $75.72 $6.85 Million - $8.23 Million
-108,736 Reduced 99.02%
1,074 $82,000
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $517,716 - $661,762
7,880 Added 7.73%
109,810 $7.99 Million
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $595,675 - $701,080
7,722 Added 8.2%
101,930 $8.21 Million
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $278,391 - $343,331
3,576 Added 3.95%
94,208 $8.69 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $3.71 Million - $4.13 Million
41,775 Added 85.5%
90,632 $8.57 Million
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $3.9 Million - $4.61 Million
43,401 Added 795.47%
48,857 $4.53 Million
Q1 2018

May 08, 2018

BUY
$92.01 - $123.21 $170,402 - $228,184
1,852 Added 51.39%
5,456 $516,000
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $123,413 - $135,333
-1,378 Reduced 27.66%
3,604 $349,000
Q3 2017

Nov 07, 2017

SELL
$69.85 - $89.22 $2.4 Million - $3.07 Million
-34,424 Reduced 87.36%
4,982 $443,000
Q2 2017

Aug 08, 2017

BUY
N/A
39,406
39,406 $2.86 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Motco Portfolio

Follow Motco and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.